22 employees
Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases.
2020
$4M
from 2 investors over 2 rounds
Galux raised $4M on December 16, 2021
Investors: DAYLI Partners and 카카오브레인 - Kakao Brain